NewAmsterdam Pharma Company N.V.
Price
FilingsNewest: 8-K, Other eventsSep 29 →InsidersNo open-market buys. 5 insiders sold $55.4M, 31 of 37 sales on a 10b5-1 plan.→PeersClosest companies: APGE, ARWR, MBX→
From the filings
Figures
- Revenue
- $7.1Mlast 12 months
- Net income
- −$258.7Mlast 12 months
- Operating cash flow
- −$141.9Mlast 12 months
- Cash and equivalents
- $424.2Mat the last balance sheet
- Shares outstanding
- 117.7M shareson issue